Garay Arpa

CIK 00019163602 companiesKENILWORTH, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001916360

Recent Transactions

21 trades

Sale
Moderna, Inc.$MRNA
Common Stock
2023-12-06$78.34/sh−564→ 3,690 total
Exercise/Conversion
Moderna, Inc.$MRNA
Restricted Stock Units
2023-12-05−1,141→ 11,405 total
Exercise/Conversion
Moderna, Inc.$MRNA
Common Stock
2023-12-05+1,141→ 4,254 total
Sale
Moderna, Inc.$MRNA
Common Stock
2023-09-06$108.40/sh−574→ 3,113 total
Exercise/Conversion
Moderna, Inc.$MRNA
Common Stock
2023-09-05+1,140→ 3,687 total
Exercise/Conversion
Moderna, Inc.$MRNA
Restricted Stock Units
2023-09-05−1,140→ 12,546 total
Sale
Moderna, Inc.$MRNA
Common Stock
2023-06-06$125.75/sh−2,290→ 2,547 total
Exercise/Conversion
Moderna, Inc.$MRNA
Common Stock
2023-06-05+4,562→ 4,837 total
Exercise/Conversion
Moderna, Inc.$MRNA
Restricted Stock Units
2023-06-05−4,562→ 13,686 total
Award
Moderna, Inc.$MRNA
Restricted Stock Units
2023-02-28+5,260→ 5,260 total
Award
Moderna, Inc.$MRNA
Stock Option (Right to Buy)
2023-02-28+20,040→ 20,040 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Common Stock
2022-05-04$87.10/sh+907→ 2,368 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Restricted Stock Unit
2022-05-04−907→ 1,819 total
Tax Payment
Merck & Co., Inc.$MRK
Common Stock
2022-05-04$87.10/sh−259→ 2,109 total
Award
Merck & Co., Inc.$MRK
Stock Option (Right to Buy)
2022-05-03+21,359→ 21,359 total
Tax Payment
Merck & Co., Inc.$MRK
Common Stock
2022-05-03$87.65/sh−221→ 1,461 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Common Stock
2022-05-03$87.65/sh+773→ 1,682 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Restricted Stock Unit
2022-05-03−773→ 0 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Common Stock
2022-05-01$88.69/sh+866→ 1,156 total
Tax Payment
Merck & Co., Inc.$MRK
Common Stock
2022-05-01$88.69/sh−247→ 909 total
Exercise/Conversion
Merck & Co., Inc.$MRK
Restricted Stock Unit
2022-05-01−866→ 866 total

Companies

Recent Filings

Address

MERCK & CO., INC. 2000 GALLOPING HILL ROAD

KENILWORTH, NJ, 07033

View on SEC.gov